Theravance Biopharma, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2012 | $130.1M | $-9.6M | $-9.6M |
| FY2013 | $226.0K | $-156.3M | $-156.3M |
| FY2014 | $11.7M | $-232.5M | $-237.0M |
| FY2015 | $42.1M | $-181.9M | $-182.2M |
| FY2016 | $48.6M | $-180.5M | $-190.7M |
| FY2017 | $15.4M | $-260.1M | $-285.4M |
| FY2018 | $60.4M | $-238.8M | $-215.5M |
| FY2019 | $73.4M | $-251.9M | $-236.5M |
| FY2020 | $71.9M | $-297.6M | $-278.0M |
| FY2021 | $55.3M | $-257.8M | $-199.4M |
| FY2022 | $51.3M | $-92.0M | $872.1M |
| FY2023 | $57.4M | $-56.0M | $-55.2M |
| FY2024 | $64.4M | $-46.9M | $-56.4M |
| FY2025 | $107.5M | $-3.6M | $105.9M |